Search

Amber D. Steele

Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )

Most Active Art Unit
1658
Art Unit(s)
1654, 1639, 1658, 1676
Total Applications
1302
Issued Applications
628
Pending Applications
166
Abandoned Applications
538

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 10911717 [patent_doc_number] => 20140314734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'COMPOSITIONS AND METHODS FOR SPECIFIC REGULATION OF PYRUVATE DEHYDROGENASE KINASE' [patent_app_type] => utility [patent_app_number] => 14/238449 [patent_app_country] => US [patent_app_date] => 2012-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 12831 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238449 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/238449
Compositions and methods for specific regulation of pyruvate dehydrogenase kinase Aug 9, 2012 Issued
Array ( [id] => 9546719 [patent_doc_number] => 20140171368 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'POLYANION NANOCOMPLEXES FOR THERAPEUTIC APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 14/237445 [patent_app_country] => US [patent_app_date] => 2012-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5749 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237445 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/237445
Polyanion nanocomplexes for therapeutic applications Aug 6, 2012 Issued
Array ( [id] => 9659076 [patent_doc_number] => 20140230081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'POLYNUCLEOTIDE, POLYPEPTIDE, ANIMAL MODEL AND METHOD FOR THE DEVELOPMENT OF COMPLEMENT SYSTEM MODULATORS' [patent_app_type] => utility [patent_app_number] => 14/237880 [patent_app_country] => US [patent_app_date] => 2012-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19435 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237880 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/237880
POLYNUCLEOTIDE, POLYPEPTIDE, ANIMAL MODEL AND METHOD FOR THE DEVELOPMENT OF COMPLEMENT SYSTEM MODULATORS Aug 5, 2012 Abandoned
Array ( [id] => 10649391 [patent_doc_number] => 09365627 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Endomucin as an anti-inflammatory agent' [patent_app_type] => utility [patent_app_number] => 14/237082 [patent_app_country] => US [patent_app_date] => 2012-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 40 [patent_no_of_words] => 8516 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237082 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/237082
Endomucin as an anti-inflammatory agent Aug 5, 2012 Issued
Array ( [id] => 12144806 [patent_doc_number] => 09879049 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-30 [patent_title] => 'Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial strains' [patent_app_type] => utility [patent_app_number] => 14/236876 [patent_app_country] => US [patent_app_date] => 2012-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 16618 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236876 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/236876
Glycopeptide antibiotic analogs effective against vancomycin-resistant bacterial strains Aug 2, 2012 Issued
Array ( [id] => 11430172 [patent_doc_number] => 09568485 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-02-14 [patent_title] => 'Method for the early diagnosis of clinically latent placental insufficiency associated with defective placental maturation' [patent_app_type] => utility [patent_app_number] => 14/233601 [patent_app_country] => US [patent_app_date] => 2012-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8217 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233601 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/233601
Method for the early diagnosis of clinically latent placental insufficiency associated with defective placental maturation Jul 19, 2012 Issued
Array ( [id] => 10906146 [patent_doc_number] => 20140309158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'COMPOSITIONS AND METHODS FOR IMMUNOMODULATION' [patent_app_type] => utility [patent_app_number] => 14/233114 [patent_app_country] => US [patent_app_date] => 2012-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 28095 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233114 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/233114
Compositions and methods for immunomodulation Jul 15, 2012 Issued
Array ( [id] => 11388733 [patent_doc_number] => 09549964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-24 [patent_title] => 'Diagnosis, prognosis, and treatment of kidney disease' [patent_app_type] => utility [patent_app_number] => 14/131866 [patent_app_country] => US [patent_app_date] => 2012-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 16 [patent_no_of_words] => 16090 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14131866 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/131866
Diagnosis, prognosis, and treatment of kidney disease Jul 12, 2012 Issued
Array ( [id] => 10614871 [patent_doc_number] => 09334306 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-10 [patent_title] => 'Leukemia stem cell targeting ligands and methods of use' [patent_app_type] => utility [patent_app_number] => 14/130909 [patent_app_country] => US [patent_app_date] => 2012-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21861 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14130909 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/130909
Leukemia stem cell targeting ligands and methods of use Jul 8, 2012 Issued
Array ( [id] => 11773466 [patent_doc_number] => 09382304 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'Engineered polypeptides having enhanced duration of action with reduced immunogenicity' [patent_app_type] => utility [patent_app_number] => 14/129815 [patent_app_country] => US [patent_app_date] => 2012-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 27 [patent_no_of_words] => 49663 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129815 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/129815
Engineered polypeptides having enhanced duration of action with reduced immunogenicity Jul 2, 2012 Issued
Array ( [id] => 10008054 [patent_doc_number] => 09051562 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 14/126253 [patent_app_country] => US [patent_app_date] => 2012-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 10277 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14126253 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/126253
Polypeptides isolated from brevibacterium aurantiacum and their use for the treatment of cancer Jun 14, 2012 Issued
Array ( [id] => 11794120 [patent_doc_number] => 09403870 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-08-02 [patent_title] => 'Methods of phosvitin extraction and phosphopeptide preparation from egg yolk' [patent_app_type] => utility [patent_app_number] => 14/123890 [patent_app_country] => US [patent_app_date] => 2012-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 11164 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14123890 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/123890
Methods of phosvitin extraction and phosphopeptide preparation from egg yolk Jun 10, 2012 Issued
Array ( [id] => 10649390 [patent_doc_number] => 09365626 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Simukunin' [patent_app_type] => utility [patent_app_number] => 14/122300 [patent_app_country] => US [patent_app_date] => 2012-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 18783 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14122300 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/122300
Simukunin May 24, 2012 Issued
Array ( [id] => 9785163 [patent_doc_number] => 20140301983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-09 [patent_title] => 'HYALURONIC ACID-BINDING SYNTHETIC PEPTIDOGLYCANS, PREPARATION, AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 14/119341 [patent_app_country] => US [patent_app_date] => 2012-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 21992 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14119341 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/119341
Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use May 23, 2012 Issued
Array ( [id] => 10600150 [patent_doc_number] => 09320698 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-26 [patent_title] => 'Peptide tyrosinase inhibitors and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/117012 [patent_app_country] => US [patent_app_date] => 2012-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 17872 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14117012 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/117012
Peptide tyrosinase inhibitors and uses thereof May 9, 2012 Issued
Array ( [id] => 9510985 [patent_doc_number] => 20140147476 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-29 [patent_title] => 'ORGANIC NANOTUBE HAVING HYDROPHOBIZED INNER SURFACE, AND ENCAPSULATED MEDICINAL AGENT PREPARED USING THE NANOTUBE' [patent_app_type] => utility [patent_app_number] => 14/116182 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 22512 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14116182 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/116182
Organic nanotube having hydrophobized inner surface, and encapsulated medicinal agent prepared using the nanotube Mar 29, 2012 Issued
Array ( [id] => 8417602 [patent_doc_number] => 20120245101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-27 [patent_title] => 'SYNTHETIC APOLIPOPROTEIN E MIMICKING POLYPEPTIDES AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 13/429022 [patent_app_country] => US [patent_app_date] => 2012-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 46933 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13429022 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/429022
SYNTHETIC APOLIPOPROTEIN E MIMICKING POLYPEPTIDES AND METHODS OF USE Mar 22, 2012 Abandoned
Array ( [id] => 10141132 [patent_doc_number] => 09173919 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Collagen-targeted nanoparticles' [patent_app_type] => utility [patent_app_number] => 14/000036 [patent_app_country] => US [patent_app_date] => 2012-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11307 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14000036 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/000036
Collagen-targeted nanoparticles Feb 15, 2012 Issued
Array ( [id] => 10422543 [patent_doc_number] => 20150307554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-29 [patent_title] => 'NTS-POLYPLEX NANOPARTICLES SYSTEM FOR GENE THERAPY OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/984548 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12023 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13984548 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/984548
NTS-POLYPLEX NANOPARTICLES SYSTEM FOR GENE THERAPY OF CANCER Feb 9, 2012 Abandoned
Array ( [id] => 8301936 [patent_doc_number] => 20120184491 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-07-19 [patent_title] => 'Methods and Compound to Inhibit Ca2+ Permeable Cation Conductance' [patent_app_type] => utility [patent_app_number] => 13/351611 [patent_app_country] => US [patent_app_date] => 2012-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 9885 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13351611 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/351611
Methods and compound to inhibit Ca2+ permeable cation conductance Jan 16, 2012 Issued
Menu